Pharmaceutical tablet
Latest Celgene Corporation Patents:
- Methods of treating cancer by targeting cold tumors
- Heterocyclic compounds and their use for treatment of helminthic infections and diseases
- Modulators of CAMKK2 as Ligand Directed Degraders
- USES OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS
- Cereblon binding compounds, compositions thereof, and methods of treatment therewith
Portions of the tablet are shown in broken lines to indicate that those portions form no part of the claimed design.
Claims
The ornamental design for a pharmaceutical tablet, as shown and described.
D31133 | July 1899 | Lantz |
D301764 | June 20, 1989 | Contractor |
D302051 | July 4, 1989 | Contractor et al. |
5770225 | June 23, 1998 | Parekh et al. |
5824338 | October 20, 1998 | Jacobs et al. |
D403396 | December 29, 1998 | Lundbom et al. |
D408910 | April 27, 1999 | Lundbom |
D425614 | May 23, 2000 | Chen et al. |
D430285 | August 29, 2000 | Chen et al. |
D431076 | September 19, 2000 | Chen |
D434846 | December 5, 2000 | Chen |
6165513 | December 26, 2000 | Dansereau et al. |
D459798 | July 2, 2002 | Desesquelle |
D506544 | June 21, 2005 | Rinker et al. |
D515202 | February 14, 2006 | Chen |
D534646 | January 2, 2007 | Chang et al. |
D535021 | January 9, 2007 | Stawski et al. |
D564086 | March 11, 2008 | Nielsen et al. |
D671636 | November 27, 2012 | Nishino |
D735315 | July 28, 2015 | Bhat |
D741990 | October 27, 2015 | Ramos |
D787042 | May 16, 2017 | Parikh |
D787043 | May 16, 2017 | Parikh |
D10612561 | October 1999 | JP |
- U.S. Appl. No. 29/531,123, filed Jun. 23, 2015, Parikh et al.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dared Apr. 6, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/524,022, dated Oct. 18, 2016.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Jan. 10, 2017.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/525,253, dated Apr. 11, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/525,253, dated Oct. 18, 2016.
- United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/525,253, dated Jan. 13, 2017.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,113, dated Apr. 12, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,113, dated Oct. 18, 2016.
- United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/531,113, dated Jan. 17, 2017.
- United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,123, dated Apr. 11, 2016.
- United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,123, dated Oct. 18, 2016.
Type: Grant
Filed: Jul 23, 2018
Date of Patent: Sep 3, 2019
Assignee: Celgene Corporation (Summit, NJ)
Inventors: Darshan Parikh (Bridgewater, NJ), Scott Burnside (Wilmington, NC), Sreenivas S. Bhat (Kendall Park, NJ), Jiping Liu (Basking Ridge, NJ)
Primary Examiner: Charles D Hanson
Application Number: 29/657,523